These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24211151)

  • 1. Socioeconomic deprivation independently predicts symptomatic painful diabetic neuropathy in type 1 diabetes.
    Anderson SG; Malipatil NS; Roberts H; Dunn G; Heald AH
    Prim Care Diabetes; 2014 Apr; 8(1):65-9. PubMed ID: 24211151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Socioeconomic deprivation independently predicts painful diabetic neuropathy in type 2 diabetes.
    Anderson SG; Narayanan RP; Malipatil NS; Roberts H; Dunn G; Heald AH
    Exp Clin Endocrinol Diabetes; 2015 Jul; 123(7):423-7. PubMed ID: 26069072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of painful diabetic peripheral neuropathy among patients suffering from diabetes mellitus in Saudi Arabia.
    Halawa MR; Karawagh A; Zeidan A; Mahmoud AE; Sakr M; Hegazy A
    Curr Med Res Opin; 2010 Feb; 26(2):337-43. PubMed ID: 19968592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus.
    Pai YW; Lin CH; Lee IT; Chang MH
    Diabetes Metab Syndr; 2018; 12(2):111-116. PubMed ID: 29042249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities.
    D'Amato C; Morganti R; Greco C; Di Gennaro F; Cacciotti L; Longo S; Mataluni G; Lauro D; Marfia GA; Spallone V
    Diab Vasc Dis Res; 2016 Nov; 13(6):418-428. PubMed ID: 27334483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of amitriptyline and duloxetine in painful diabetic neuropathy: a randomized, double-blind, cross-over clinical trial.
    Kaur H; Hota D; Bhansali A; Dutta P; Bansal D; Chakrabarti A
    Diabetes Care; 2011 Apr; 34(4):818-22. PubMed ID: 21355098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
    Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
    Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M; Cogni G; Sacchi L; Dagliati A; Marini S; Tibollo V; De Cata P; Bellazzi R; Chiovato L
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Painful diabetic neuropathy.
    Peltier A; Goutman SA; Callaghan BC
    BMJ; 2014 May; 348():g1799. PubMed ID: 24803311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of DN4 questionnaire in assessment of neuropathic pain and its clinical correlations in Turkish patients with diabetes mellitus.
    Celik S; Yenidunya G; Temel E; Purisa S; Uzum AK; Gul N; Cinkil G; Dinccag N; Satman I
    Prim Care Diabetes; 2016 Aug; 10(4):259-64. PubMed ID: 26749091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of diabetic peripheral neuropathy in Type 2 diabetes mellitus patients with overweight/obese in Guangdong province, China.
    Li L; Chen J; Wang J; Cai D
    Prim Care Diabetes; 2015 Jun; 9(3):191-5. PubMed ID: 25163987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic asymmetric proximal neuropathy].
    Kotov SV; Rudakova IG; Isakova EV; Belova YA; Volchenkova TV; Khirbek M; Stashuk GA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):59-62. PubMed ID: 28252606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does treatment with duloxetine for neuropathic pain impact glycemic control?
    Hardy T; Sachson R; Shen S; Armbruster M; Boulton AJ
    Diabetes Care; 2007 Jan; 30(1):21-6. PubMed ID: 17192327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine for treating painful neuropathy or chronic pain.
    Lunn MP; Hughes RA; Wiffen PJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007115. PubMed ID: 19821395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health care costs in patients with painful diabetic peripheral neuropathy prescribed pregabalin or duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Mar; 12(3):209-18. PubMed ID: 21676163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.
    Qureshi MS; Iqbal M; Zahoor S; Ali J; Javed MU
    J Endocrinol Invest; 2017 Apr; 40(4):425-430. PubMed ID: 27848229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.
    Abbott CA; Malik RA; van Ross ER; Kulkarni J; Boulton AJ
    Diabetes Care; 2011 Oct; 34(10):2220-4. PubMed ID: 21852677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
    Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
    Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.